dihexa cancer risk c-met

dihexa cancer risk c-met Targeting in gastrointestinal tumours: rationale, opportunities and challenges dihexa hgf c-met cancer risk

Name: dihexa cancer risk c-met Targeting in gastrointestinal tumours: rationale, opportunities and challenges dihexa hgf c-met cancer risk
Brand: tmdnewgeneration.cz
SKU: 29487514389
Price: 20.03 USD
Availability: InStock
Rating: 4.5697 (11 reviews)

dihexa hgf c met cancer risk Role of the HGF c MET tyrosine kinase inhibitors in Molecular mechanism(s) of regulation(s) of dihexa cancer risk hgf c met Unveiling the Role of HGF c Met Signaling in Non Small Cell Lung Tumor Microenvironment dihexa hgf c met agonist Anti cancer The role of MET in chemotherapy resistance Oncogene The c MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti cancer agents ScienceDirect

SKU: 29487514389 · From tmdnewgeneration.cz

4.6

USD20.03 USD63.03

Pay in 4 interest-free payments of $5.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

However, peptide pens simplify the process while improving accuracy

Dihexa has also been patented for potential use in treating Alzheimers and Parkinsons disease, though human clinical evidence remains in early stages

Research has demonstrated that Dihexa binds to HGF with remarkably high affinity (Kd = 65 picomolar) and acts as an allosteric modulator, potentiating HGF activity even at subthreshold concentrations